ALZN has 36-month beta value of -0.18. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ALZN is 6.31M, and currently, short sellers hold a 1.92% ratio of that float. The average trading volume of ALZN on March 28, 2025 was 386.83K shares.
ALZN) stock’s latest price update
Alzamend Neuro Inc (NASDAQ: ALZN) has experienced a rise in its stock price by 10.00 compared to its previous closing price of 1.00. However, the company has seen a gain of 12.44% in its stock price over the last five trading days. globenewswire.com reported 2025-03-25 that ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) — Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with Alzheimer’s in the fourth quarter of 2025. This study follows the successful completion of a head coil by Tesla Dynamic Coils BV, a key component of the clinical trial.
ALZN’s Market Performance
ALZN’s stock has risen by 12.44% in the past week, with a monthly rise of 27.24% and a quarterly drop of -4.35%. The volatility ratio for the week is 10.21% while the volatility levels for the last 30 days are 10.70% for Alzamend Neuro Inc The simple moving average for the past 20 days is 30.47% for ALZN’s stock, with a -44.76% simple moving average for the past 200 days.
Analysts’ Opinion of ALZN
Many brokerage firms have already submitted their reports for ALZN stocks, with Ascendiant Capital Markets repeating the rating for ALZN by listing it as a “Buy.” The predicted price for ALZN in the upcoming period, according to Ascendiant Capital Markets is $8 based on the research report published on October 01, 2021 of the previous year 2021.
ALZN Trading at 11.05% from the 50-Day Moving Average
After a stumble in the market that brought ALZN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.70% of loss for the given period.
Volatility was left at 10.70%, however, over the last 30 days, the volatility rate increased by 10.21%, as shares surge +31.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.65% lower at present.
During the last 5 trading sessions, ALZN rose by +12.44%, which changed the moving average for the period of 200-days by -81.03% in comparison to the 20-day moving average, which settled at $0.8431. In addition, Alzamend Neuro Inc saw -5.17% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALZN starting from Horne William B., who purchase 3,334 shares at the price of $0.99 back on Mar 26 ’25. After this action, Horne William B. now owns 30,000 shares of Alzamend Neuro Inc, valued at $3,285 using the latest closing price.
AULT MILTON C III, the Director of Alzamend Neuro Inc, purchase 2,905 shares at $1.02 during a trade that took place back on Mar 21 ’25, which means that AULT MILTON C III is holding 85,273 shares at $2,969 based on the most recent closing price.
Stock Fundamentals for ALZN
Current profitability levels for the company are sitting at:
- -55.29 for the present operating margin
- 0.67 for the gross margin
The net margin for Alzamend Neuro Inc stands at -55.54. The total capital return value is set at -1.22. Equity return is now at value -1092.96, with -168.13 for asset returns.
Currently, EBITDA for the company is -9.89 million with net debt to EBITDA at 0.81. When we switch over and look at the enterprise to sales, we see a ratio of 51.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.44.
Conclusion
To put it simply, Alzamend Neuro Inc (ALZN) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
